COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 460

Article download: 160

Indian Journal of Pathology and Oncology

Myxoid Neurothekeoma: Report of a rare tumour at unusual site

Full Text PDF Share on Facebook Share on Twitter

Author Details : Shubbhangi Vinayak Agale, Shubhangi Narayan Jibhkate, Akshay Tiwari, Sushma Bharti

Volume : 4, Issue : 3, Year : 2017

Article Page : 476-478

Suggest article by email


Introduction: Neurothekeoma is a rare benign soft tissue tumor of uncertain histogenesis which affects adolescents and young adults. It is rare to find these tumors occurring in children. Neurothekeoma usually presents with a small, solitary, and slow-growing nodule or papule on the upper body.
Case Report: We describe a case of a 9-year-old girl having large (5x4x1) painful swelling over back of 2 months duration. After total resection of the tumor, histological examination and immunostaining confirmed the diagnosis of myxoid neurothekeoma. The clinicopathological features of this rare tumor and its important differential diagnoses are discussed.
Conclusion: Neurothekeoma is a rare tumour in children and its’ myxoid variant is even rarer. This benign tumour has to be differentiated from other malignant tumors as it has good prognosis.

Nerve sheath tumour, Myxoid, Neurothekeoma

How to cite : Agale S V, Jibhkate S N, Tiwari A, Bharti S, Myxoid Neurothekeoma: Report of a rare tumour at unusual site. Indian J Pathol Oncol 2017;4(3):476-478

Copyright © 2017 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (